Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2025 04:00 ET | Source: Alvotech

Alvotech vinnur sigur í mikilvægu dómsmáli um framleiðslu og markaðssetningu AVT06 hliðstæðunnar við Eylea (aflibercept)

Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að dómstóll í Bretlandi hafi hafnað lögbannskröfu Regeneron Pharmaceuticals og Bayer sem beindist að Alvotech og þjónustuaðila félagsins í Bretlandi....
November 10, 2025 04:00 ET | Source: Alvotech

UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)

REYKJAVIK, ICELAND (November 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced...
February 01, 2024 07:56 ET | Source: Semantix, Inc.

Semantix and SPC Grafeno Form Strategic Partnership to Enhance Brazil’s Credit Market

Semantix and SPC Grafeno Form Strategic Partnership to Enhance Brazil’s Credit Market